2018
DOI: 10.1080/13816810.2018.1495745
|View full text |Cite
|
Sign up to set email alerts
|

Gene therapy in inherited retinal degenerative diseases, a review

Abstract: Hereditary diseases of the retina represent a group of diseases with several heterogeneous mutations that have the common end result of progressive photoreceptor death leading to blindness. Retinal degenerations encompass multifactorial diseases such as age-related macular degeneration, Leber congenital amaurosis, Stargardt disease, and retinitis pigmentosa. Although there is currently no cure for degenerative retinal diseases, ophthalmology has been at the forefront of the development of gene therapy, which o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
41
0
7

Year Published

2019
2019
2022
2022

Publication Types

Select...
6
2
2

Relationship

2
8

Authors

Journals

citations
Cited by 56 publications
(48 citation statements)
references
References 82 publications
0
41
0
7
Order By: Relevance
“…The diagnosis of inherited retinal dystrophy (IRD) includes a group of genetic retinal disorders that affect the photoreceptors and retinal pigment epithelium. Manifestations of the disease are characterized by clinical and genetic heterogeneity . IRD encompasses syndromic and non‐syndromic conditions, with some overlap in terms of clinical hallmarks .…”
Section: Introductionmentioning
confidence: 99%
“…The diagnosis of inherited retinal dystrophy (IRD) includes a group of genetic retinal disorders that affect the photoreceptors and retinal pigment epithelium. Manifestations of the disease are characterized by clinical and genetic heterogeneity . IRD encompasses syndromic and non‐syndromic conditions, with some overlap in terms of clinical hallmarks .…”
Section: Introductionmentioning
confidence: 99%
“…With advances in the fields of genetic engineering and stem cell research, gene therapy and photoreceptor transplantation have emerged as promising treatment strategies for patients with USH2A mutations [7][8][9]. Identifying individuals who will most benefit from these therapies is critical for successful treatment outcomes; this can be accomplished by examining the association between genetic defects and clinical phenotypes.…”
Section: Introductionmentioning
confidence: 99%
“…A great body of work has been dedicated to developing rodent models that capture the critical aspects of human diseases and there are currently >100 different types of visually impaired mouse . A particular focus has been devoted to using these models to develop treatments based on optogenetics, stem cell therapies and gene therapies for such incurable conditions as retinitis pigmentosa and Leber congenital amaurosis (Auricchio et al, 2017;Busskamp et al, 2012;Takahashi et al, 2018).…”
Section: Introductionmentioning
confidence: 99%